Neuro Kinetics, Inc. (NKI) is the world leader in eye tracking technology and non-invasive neuro-otologic diagnostic testing for over 30 years. Central to our I-Portal® product mix and advances in clinical eye tracking is the premise that the eye is the portal to the brain. Research has shown the detection of abnormal eye movements can indicate the presence of over 200 diseases and medical conditions.
Address: 128 Gamma Dr, Pittsburgh, PA 15238
Driving Directions ››
Business Hours: 8am – 5pm, Monday-Friday
Neuro Kinetics, Inc. (NKI), the world leader in clinical eye-tracking and non-invasive neurotologic diagnostic testing, has the Science to See™ neuro-functional biomarkers invisible to the naked eye. Research shows that abnormal eye responses can help to diagnose more than 200 diseases and medical conditions. With 22 issued patents and over 140+ installations around the globe, NKI’s FDA cleared I-Portal® devices are sold to audiologists, ENT specialists, physical therapists, neurotologists, ophthalmologists, neuro-ophthalmologists, chiropractors, and neurologists. The company’s FDA-cleared diagnostic platforms include the I-PAS™, I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG, (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training, and support services.
Contact 412.963.6649 or email@example.com for more information.
Writing About NKI?
- Neuro Kinetics, Inc. (NKI) was established in 1984
- CEO & President: J. Howison Schroeder
- Headquarters: Pittsburgh, Pennsylvania
- 22 U.S. patents issued and 10 U.S. patents pending
Visit the Media Room